Angiotensin II (Ang II), whose generation largely depends on angiotensin-converting enzyme (ACE) activity, mediates most of the renin-angiotensin-system (RAS) effects. Elastase-2 (ELA-2), a chymotrypsin-serine protease elastase family member 2A, alternatively generates Ang II in rat arteries. Myocardial infarction (MI) leads to intense RAS activation, but mechanisms involved in Ang II-generation in resistance arteries are unknown. We hypothesized that ELA-2 contributes to vascular Ang II generation and cardiac damage in mice subjected to MI.
Introduction
Myocardial infarction (MI) is associated with complex neurohumoral interactions among the heart, brain, kidney and peripheral vasculature. Impaired cardiac function in congestive heart failure (CHF) results in low cardiac output and arterial underfilling. Decreased stretching of the high and low-pressure baroreceptors and hypoperfusion-mediated stimulation of chemoreceptors enhances sympathetic tone (Ledoux et al., 2003) . These processes increase peripheral vascular resistance by direct stimulation of smooth muscle contraction and also through activation of the reninangiotensin system (RAS).
The RAS modulates a wide variety of functions in the cardiovascular and renal systems, playing an integral role in the homeostatic control of arterial blood pressure, tissue perfusion and extracellular volume (Paul et al., 2006; Bader and Ganten, 2008; Te Riet et al., 2015) . In the setting of MI and CHF, activation of the RAS, mainly through angiotensin II (Ang II) generation, induces vasoconstriction and further increases peripheral resistance. The increased resistance is thought to be a compensatory mechanism to maintain perfusion of vital organs by sustaining blood pressure in the fate of a failing heart. Ang II also increases blood volume due to aldosterone stimulation, which promotes sodium and water retention, and increases sympathetic activity. In the long term, these processes are deleterious, further impairing cardiac function (Schrier and Abraham, 1999) .
Local vascular mechanisms are also important contributors to increased arterial resistance. Locally generated Ang II, released by the endothelium and terminal nerves, contributes to MI-/CHF-associated vascular remodelling (Fang and Marwick, 2002) . Therefore, an understanding of the pathways that contribute to vascular Ang II generation can reveal pathological mechanisms contributing to post-MI-associated vascular dysfunction.
Acute MI significantly increases the expression of several myocardial RAS components, including Ang II (Oyamada et al., 2010) . Patients with heart failure present progressive increases in cardiac Ang II formation, but no changes in AT 1 receptor density, in the failing myocytes (Serneri et al., 2001) . In addition, RAS blockade with angiotensinconverting enzyme (ACE) inhibitors significantly reduces the mortality of patients with heart failure after MI (Pfeffer et al., 1992 (Pfeffer et al., , 2003 Torp-Pedersen and Køber, 1999) . In this context, the beneficial effects of ACE inhibitors for the treatment of cardiovascular diseases are well established. However, patients chronically treated with effective doses of ACE inhibitors do not show suppression of Ang II formation (Jorde et al., 2000; Farquharson and Struthers, 2002) , suggesting a role for ACE-independent alternative pathways in Ang II generation. Ang II formation is also preserved in the kidney, heart and lungs of mice with ACE deletion (Wei et al., 2002) . These findings reinforce an important contribution of alternative pathways to Ang II generation in several conditions. Indeed, other enzymes have been shown to contribute to Ang II generation (Balcells et al., 1997) .
Elastase-2 (ELA-2), an Ang II-generating chymotrypsinserine protease elastase family member 2A, is widely found in several organs, such as the lung, pancreas, liver, blood vessels (mesenteric and carotid arteries), heart and kidney of rodents (Santos et al., 2003; Becari et al., 2005 Becari et al., , 2011a . The importance of this functional alternative pathway for Ang II generation was demonstrated in heart, carotid and mesenteric arteries from normotensive and spontaneously hypertensive (SHR) rats (Santos et al., 2003; Becari et al., 2005 Becari et al., , 2011a . In addition, chronic treatment with enalapril, an ACE inhibitor, increases ELA-2 contribution to Ang II generation in the carotid artery of SHR and normotensive rats (Becari et al., 2011b) . Thus, considering that acute MI significantly increases Ang II generation, we sought to determine whether ELA-2 contributes to vascular Ang II generation and possibly to cardiac damage upon MI. In the present study, we assessed cardiac function and Ang II generation in peripheral resistance arteries of wild type (WT) and ELA-2 knockout (ELA-2 KO) mice, subjected to sham-surgery or MI.
Methods

Animals
Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015 
Genotyping
Tail tissue genomic DNA was obtained, and it was used to amplify the target gene by PCR. The expected amplicon size for the knockout allele amplified with primers ElaF: (5´AGAAACTATGTCTGCTATGTCAC 3´) and pELAloxr2: (5´TTCTTGAACTGATGGCGAGC 3´) is 295pb, and the WT allele should yield an amplicon of 345pb with primers ElaF and ElaWTr (5´TTTACAGATGAGGAAGTCACC 3´).
Myocardial infarction. The technical procedure used to provoke MI was performed as reported previously (SaltoTellez et al., 2004; Durand et al., 2014; Corrêa et al., 2015) . Briefly, under isoflurane anaesthesia, a ventral midline skin incision was made caudally to the larynx to access the trachea; then, a small incision was made in the trachea to introduce a 22G needle tip (BD Angiocath Becton Dickinson Ind. Cir. Ltda., Juiz de Fora, MG, Brazil), which was connected to a rodent ventilator (Inspira Advanced Safety Single Animal Pressure/Volume Controlled Ventilator, Harvard Apparatus, Holliston, MA, USA). The rodent ventilator acquired the anaesthetic mixture from the isoflurane vaporizer. An 80 μL tidal volume was maintained at 70 cycles min À1 . After the skin was shaved and disinfected, the third intercostal space was opened, the heart was visualized and the pericardium was gently opened. The left anterior descending coronary artery was visualized and ligated with an 8-0 polypropylene suture. The intercostal incision was closed with a 6-0 silk suture, and a 21G needle attached to a 3.0 mL syringe was introduced through the closed wound, and the negative pressure of the thorax was re-established, whilst avoiding damage to the heart and lungs. Finally, the skin was closed with a 6-0 silk suture. In the mouse second-order mesenteric arteries, the cumulative concentrations of Ang II and Ang I produced bell-shaped concentration-response curves, as observed in the rat carotid artery (Becari et al., 2005 were performed at the point of greatest cavity dimension, and systolic measurements were made at the point of minimal cavity dimension, using the leading edge method of the American Society of Echocardiography (Lang et al., 2015) . Ejection fraction and fractional shortening were calculated and used as determinants of left ventricle (LV) systolic function.
Histology. Mice were killed by CO 2 inhalation, 4 weeks after the MI surgery, the mesenteric arterial bed was removed and the whole heart was harvested, rinsed in 10% KCl solution (to stop the heart in diastole) and weighed. The hearts were cut transversely and fixed in phosphate-buffered 10% formalin for 24 to 48 h. For histological processing, the hearts were embedded into paraffin and each block was serially cut in 6 μm thickness slices. The sections were stained with picrosirius red. Assessment of the infarct size was performed according to Takagawa et al. (2007) . Briefly, the infarct size (%) was calculated by dividing the infarct length -between the surfaces of the epicardium and endocardium -by the circumference of the left ventricle and multiplying by 100. To accomplish this, sections were analysed using the video microscopy software Leica Qwin (Leica Imaging Systems, Cambridge, UK) and the publicdomain software NIH ImageJ (developed by U.S. National Institutes of Health and available at http://rsb.info.nih.gov/ nih-image/).
BJP C Becari et al.
Group sizes/randomization/blinding
Experiments were carried out in WT and ELA-2 KO mice, which were randomly assigned to sham surgery or MI (MI groups). In the groups sham ELA-2 KO, sham WT and MI ELA-2 KO, 5 independent experiments were performed for all experimental protocols. In the group, MI-WT, 6 independent experiments were performed for echocardiographic, histology and vascular reactivity protocols. The cumulative concentration-response curves to Ang I and Ang II and the histological protocols were performed by one of the authors, and the analyses were performed by other authors who were blinded for the experimental groups. Therefore, experiments and analyses were performed by independent researchers.
Statistical analyses and normalization. The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Log transformation was used in the concentration-effect curves to Ang II and Ang I, which were analysed using nonlinear regression (GraphPad Prism Software). PD 2 values and maximum contractile (Emax) responses were obtained. The pD 2 value was defined as the negative logarithm of the agonist concentration required to produce 50% of the maximum response. At least four preparations were obtained from each mouse, and one vessel from each animal received a particular treatment; n = number of animals from which the arterial rings were obtained. Statistical analyses were performed by Student's unpaired t-test or ANOVA followed by the Newman-Keuls' post hoc test, as appropriate. The post hoc test was used only when P < 0.05. Values are expressed as the mean ± SEM of n independent experiments. Comparisons of the general characteristics of the mouse studied and morphological parameters were performed using two-way ANOVA.
Results
General characteristics of mice subjected to sham surgery or myocardial infarction
The general characteristics of WT and ELA-2 KO mice subjected to sham-surgery or MI are shown in Table 1 . Body weight, heart weight and cardiac index were similar in the four groups. No differences in the survival rate after MI were observed between WT and ELA-2 KO mice. The infarct size was similar in hearts from WT (29.5 ± 9%) and ELA-2 KO (32 ± 4%) mice (Table 1 ). Figure 1A shows representative cross section of hearts, stained with picrosirius red, from WT and ELA-2 KO mice subjected to sham-surgery or MI. Figure 1B shows representative echocardiographic M mode images of hearts from WT and ELA-2 KO mice subjected to sham-surgery or MI. WT animals exhibited a significant larger LV diameter than ELA-2 KO mice during both diastole (4.1 ± 0.03 vs. 3.7 ± 0.07 mm, P < 0.05, respectively) and systole (3.2 ± 0.09 vs. 2.6 ± 0.16 mm, P < 0.05, respectively). The reduced LV diameter in ELA-2 KO mice is not related to differences in heart and body weights between the strains. The differences in LV diameters were not observed in infarcted mice. Cardiac function assessment showed that MI decreased, as expected, ejection fraction in both strains (WT: sham, 50.7 ± 5.3% vs. infarcted, 30.0 ± 3.8%; ELA-2 KO: sham, 59.1 ± 2.1% vs. infarcted 37.5 ± 1.1%; Figure 1C ). Fractional shortening was also decreased in both strains (WT: sham, 21.8 ± 1.6% vs. infarcted, 13.5 ± 2.0%; ELA-2 KO: sham, 29.6 ± 2.9% vs. infarcted 16.9 ± 1.1%; Figure 1D ). Furthermore, sham-ELA-2 KO mice exhibited a significant lower cardiac output and stroke volume compared with WT mice. MI decreased stroke volume and cardiac output in WT, but not in ELA-2 KO mice (Table 2) .
Echocardiographic analysis
ELA-2 functional analysis in mice mesenteric resistance arteries
Although the ELA-2 contribution for Ang II generation in the rat mesenteric arteries has already been described (Becari et al., 2005 (Becari et al., , 2011b Santos et al., 2003) , we compared whether the enzymatic characteristics of mouse ELA-2 are similar to those of rat ELA-2. After determining that the genomic sequence of rat ELA-2 and mice ELA-2 exhibits 89% of similarity (http//:www.ncbi.nlm.nih.gov, rat ELA-2: NM_012553 vs. mice ELA-2: NM_007919) and that ELA-2 expression is detected in many tissues (mesenteric arterial bed, heart, carotid, kidney) from both rat and mouse, we compared the proteolytic products of rat and mouse ELA-2 in the mesenteric arterial bed perfusates. Briefly, rat and mouse mesenteric arterial beds were recirculated with Krebs buffer for 6 h, and mesentery perfusate proteolytic activities, using Ang II and Ang I (30 nmol, for 30 min, at 37°C), were determined. As shown in the Supporting Information Figure S1 , the HPLC profile of the rat mesenteric arterial bed perfusate -catalysed cleavage of Ang I, Ang II -was similar Table 1 General characteristics of WT and ELA-2 knockout mice subjected to sham-surgery or myocardial infarction (MI)
Body weight (g) 26 ± 1 29 ± 2 28 ± 0.6 28 ± 3
Heart weight (mg) 137 ± 6 135 ± 7 148 ± 7 144 ± 7
Cardiac weight index (mg·g À1 ) 4.8 ± 0.2 4.7 ± 0.3 5.2 ± 0.3 5.2 ± 0.4
Infarct size (% of LV) --29.5 ± 9 32 ± 4
Values are presented as mean ± SEM of n = 5.
Elastase-2 in myocardial infarction BJP to the mouse mesenteric arterial bed perfusate. In addition, we investigated the Ang I fragments generated in the absence and in the presence of the metalloproteinase (MMP) inhibitor (o-phen), and the serine protease inhibitors (SBTI, chymostatin). ELA-2 is equally sensitive to most generalpurpose serine protease inhibitors as chymostatin, SBTI and BJP C Becari et al.
PMSF. As observed in the Supporting Information Figure S1 , rat and mice mesenteric arterial bed perfusates contained Ang II, Ang-(1-7) and Ang-(1-9) formed from Ang I. To confirm that ELA-2 contributes to Ang II generation in mesenteric resistance arteries and to test whether arteries from ELA-2 KO mice have another alternative Ang II-generating pathway, the constrictor responses induced by Ang II and Ang I were determined in the presence of chymostatin (a serine protease inhibitor) or vehicle. Chymostatin did not affect responses to Ang II (Figure 2A ) in either group. In mesenteric arteries from sham-WT mice, chymostatin significantly attenuated Ang I-induced maximal response and induced a rightward-shift of Ang I concentration-response curves ( Figure 2B ). Chymostatin did not affect the responses to Ang I in mesenteric arteries from sham-ELA-2 KO ( Figure 2C ). Responses to Ang I were attenuated in the presence of losartan, an AT 1 receptor antagonist (data not shown). These data clearly indicate that serine proteases contribute to Ang II generation in mice mesenteric resistance arteries and that ELA-2 is the major alternative Ang II-generating enzyme in these arteries.
Contribution of ELA-2 to Ang I responses in mesenteric arteries from mice subjected to myocardial infarction
To investigate possible alterations in ELA-2 contribution to the constrictor responses induced by Ang I and Ang II in mice subjected to MI, concentration-response curves to Ang I and Ang II were performed in mesenteric arteries from WT and ELA-2 KO mice subjected to sham-surgery or MI. Constrictor responses induced by Ang I were similar between mesenteric arteries from sham-WT and sham-ELA-2 KO mice ( Figure 3A) . Ang I cumulative concentration-effect curves were shifted to the left, and the maximum effect was increased in mesenteric arteries of WT mice subjected to MI (MI-WT) compared with sham-WT (Emax = 11.9 ± 1.1 vs. 7.25 ± 1.1 mN, respectively; P < 0.05; Figure 3B ). No differences were observed in vascular reactivity to Ang I between ELA2 KO subjected to MI (MI-ELA-2 KO) and sham-ELA-2 KO mice ( Figure 3C ). Accordingly, increased responses to Ang I were observed in mesenteric arteries of WT mice subjected to MI when compared with MI-ELA-2 KO mice (Emax = 11.9 ± 1.1 vs. 5.54 ± 1.6 mN, respectively; P < 0.05; Figure 3D ]. It is noteworthy that MI did not result in any significant changes in the responses induced by Ang II (Figure 4 ) in mesenteric arteries from the four groups. These data confirm that MI is associated with increased activation of the RAS (i.e. increased Ang II generation in mesenteric arteries) and provide the first evidence that ELA-2 is responsible for the increased Ang II-generating activity, at least in mesenteric-resistance arteries, upon MI.
Assessment of Ang I conversion to Ang II by ACE in mesenteric arteries from mice subjected to myocardial infarction Captopril induced a rightward-shift of the concentrationresponse curves to Ang I in mesenteric arteries from WT mice subjected to sham-surgery as well as to MI (pD 2 : sham-WT = from 7.7 ± 0.2 to 5.4 ± 0.4; P < 0.05; MI-WT = from 8.0 ± 0.15 to 5.7 ± 0.12; P < 0.05) ( Figure 5A ). Captopril did not affect the contractile responses induced by Ang II (data not shown). In arteries from ELA-2 KO mice, captopril induced a similar rightward-shift of the concentration-response curves to Ang I (pD 2 : sham-ELA-2
Figure 2
Cumulative concentration-response curves to (A) Ang II (10 À10 to 10 À8 M) and (B and C) Ang I (10 À10 to 10 À7 M) in mesenteric resistance arteries from WT and ELA-2 KO, mice, respectively, in the presence of vehicle or chymostatin (10 À4 M). Data are expressed as mean ± SEM (n = 5; n = number of animals from which the arterial rings were obtained.). *P < 0.05, Student's t-test.
Elastase-2 in myocardial infarction BJP KO = from 7.7 ± 0.22 to 5.3 ± 0.3; P < 0.05; MI-ELA-2 KO = from 7.9 ± 0.43 to 5.5 ± 0.31; P < 0.05) ( Figure 5B ; n = 4-5). Similarly, captopril did not affect the contractile responses induced by Ang II (data not shown). Considering that the magnitude of the displacement of Ang I curves in the presence of captopril was similar in both strains, these data indicate that ACE similarly contributes to Ang I conversion to Ang II in WT and ELA-2 KO mice. The contractile effects of Ang I and Ang II were abolished in the presence of the AT 1 receptor antagonist losartan (data not shown). Attenuation of the contractile effects of Ang I and Ang II by losartan indicates that Ang II induces vasoconstriction via AT 1 receptor activation. Furthermore, our data show that ELA-2 KO mice do not exhibit altered ACE activity.
Discussion
The present study confirms that MI is also associated with increased activation of the RAS in peripheral vascular beds since Ang I-induced contractions were augmented in mesenteric resistance arteries of sham mice subjected to MI. The fact that MI did not affect the contractile responses to Ang I in ELA-2 KO mice provides the first evidence that ELA-2 may be responsible for the increased Ang II-generating activity upon MI. The data also implicate ELA-2 as a key
Figure 3
Cumulative concentration-response curves to Ang I (10 À10 to 10 À7 M) in mesenteric arteries from WT and ELA-2 KO mice subjected to sham-surgery or myocardial infarction (MI). Data are expressed as mean ± SEM (n = 5; n = number of animals from which the arterial rings were obtained.). *P ≤ 0.05, Student's t-test
Figure 4
Cumulative concentration-response curves to Ang II (10 À10 to 3 × 10 À10 M) in mesenteric arteries from WT and ELA-2 KO mice subjected to sham-surgery or myocardial infarction (MI). Data are expressed as mean ± SEM (n = 5; n = number of animals from which the arterial rings were obtained.).
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player in ACE-independent dysregulation of the RAS in MI and, possibly, other cardiovascular diseases. The RAS has been described as a cascade of events with renin being released by the juxtaglomerular kidney cells, producing Ang I from the circulating angiotensinogen. Despite the characterization of new biologically active peptides in the RAS, Ang II is still considered the most important hormone in this system. Ang II is not only a circulating hormone but it is also locally produced in various tissues, acting both as an autocrine and a paracrine hormone and inducing several effects on the cardiovascular and renal systems (Dzau et al., 1988; Paul et al., 2006; Bader and Ganten, 2008) . Therefore, it is fundamental to understand the Ang II generation pathways in both physiological and pathological conditions.
Heart failure is associated with RAS hyperactivity, and MI significantly increases the expression of several RAS components, including Ang II levels in the myocardium (Oyamada et al., 2010) . Considering that MI leads to intense RAS activation and ELA-2 is increased in cardiovascular diseases such as arterial hypertension (Becari et al., 2011b) , we sought to investigate whether ELA-2 contributes to Ang II generation in mesenteric resistance arteries of mice subjected to MI. Salto-Tellez et al. (2004) demonstrated that the histological cardiac changes found in infarcted mice are similar to those observed in humans, highlighting the importance of this model for translational studies. In this study, the myocardial infarcted area, determined by histological analysis, was similar in ELA-2 KO and WT mice.
The fact that echocardiographic analysis showed no differences in cardiac function -represented by similar fractional shortening and ejection fraction -between the two strains provides evidence that the technical procedure was similarly and successfully employed in both groups, resulting in similar grades of cardiac dysfunction. This finding attenuates an eventual skewed issue concerning the vascular functional studies. Although sham-ELA-2 KO mice exhibited a significant smaller LV diameter, there were no significant differences in the LV chamber dimension between mice from the two strains subjected to MI, indicating similar cardiac structural changes in these animals. Whereas cardiac ejection fraction and fractional shortening were similarly decreased in WT and ELA-2 KO mice after MI, decreased stroke volume and cardiac output was observed in WT, but not in ELA-2 KO mice. These data indicate that ELA-2 modulates cardiac function and may contribute to post-MI cardiac dysfunction. Further support to this suggestion comes from data from our laboratory (Becari et al., 2013) , showing that ELA-2 KO mice exhibit decreased heart rate and cardiac autonomic unbalance characterized by reduced cardiac sympathetic and increased parasympathetic tone. Ang II has positive chronotropic and inotropic effects on the heart (Lambert, 1995; Beaulieu and Lambert, 1998; Patil et al., 2011) , actions mediated by AT 1 receptor and that can involve the autonomic nervous system Patil et al., 2011) . ELA-2 deletion-associated decreased basal heart rate, cardiac output and stroke volume as well as reduced parasympathetic component of heart rate variability in patients with cardiovascular diseases (Kawada et al., 2009) and amelioration of indices of parasympathetic tone after treatment with an ACE inhibitor in patients with MI (Binkley et al., 1993) suggest that local Ang II generation, possibly via ELA-2 activity, plays an important role in cardiac regulation.
The deletion of ELA-2 in mice decreased basal heart rate and stroke volume, indicating that ELA-2 may play a role in maintaining cardiac heart rate and contractility. Recently, our group showed ELA-2 KO mice present significant dysregulation in the cardiac sympathovagal balance, characterized by increased parasympathetic and reduced sympathetic modulation (Becari et al., 2013) . Moreover, the Elastase-2 in myocardial infarction BJP lower heart rate, cardiac output, stroke volume and reduced LV are also interesting findings that might be related to the autonomic dysregulation or associated with overall systemic change. These data indicate that ELA-2 may play a role on basal cardiac function and peripheral resistance. Increased peripheral resistance, a hallmark of chronic heart failure after MI (Schrier and Abraham, 1999) , has been primarily attributed to neurohumoral pathways, and it may involve both the RAS and sympathetic nervous systems (Zelis and Flaim, 1982; Gschwend et al., 2003) . The increased vascular resistance is considered a compensatory mechanism to maintain organs perfusion by sustaining blood pressure in the fate of a failing heart. Local mechanisms have been presented as important contributors to increased vascular resistance and vascular remodelling in this disease (Gschwend et al., 2003; Ledoux et al., 2003) . Gschwend et al. (2003) has shown that constriction of pressurized small mesenteric arteries is enhanced in a coronary artery ligationinduced MI model of CHF. Increased vasoconstriction appears to be tightly linked to increased levels of local Ang II or constitutive up-regulation of the AT 1 receptor. These observations reinforce the importance of assessing local Ang II generation in peripheral resistance arteries upon MI. The fact Ang II generation is increased after MI and, further, that ELA-2 is responsible for Ang II generation in mice mesenteric resistance arteries subjected to MI provides novel information about the role of alternative Ang II generation pathways in pathological conditions. ELA-2 belongs to the chymotrypsin-like elastase family, member 2A. The amino-terminal sequence of the first 10 residues of this enzyme was found to be identical to the rat pancreatic ELA-2 (EC 3.4.21.71), and the enzyme was called Ang II-forming ELA-2 of rat mesenteric arterial bed (Paula et al., 1998) . The sequencing of cDNAs for pancreatic ELA-2 and rat mesenteric arterial bed showed that they were identical (MacDonald et al., 1982; Santos et al., 2002a,b) . ELA-2 is considered the only representative of this family of proteases that is secreted outside the digestive tract and is involved in Ang II generation. ELA-2 contribution as a functional alternative pathway for vascular Ang II generation was previously demonstrated in rat mesenteric arterial bed (Santos et al., 2002a,b; and in carotid arteries from normotensive and SHR (Becari et al., 2005 (Becari et al., , 2011a . ELA-2 mRNA expression has been found in mesenteric and carotid arteries, pancreas, lung, heart, kidney, liver and spleen (Santos et al., 2003; Becari et al., 2011b) . ELA-2 is also present in the perfusate of isolated rat hearts (Becari et al., 2010) . Enalapril, an ACE inhibitor, increases the contribution of ELA-2 to Ang II formation in carotid arteries and hearts of normotensive and hypertensive rats (Becari et al., 2011b) . Similar to ACE, a notable feature of ELA-2 is the high catalytic converting activity of Ang I to Ang II (kcat/km = 42.5 min À1 ·mM À1 ) and the inability to destroy the Ang II just produced (Paula et al., 1998) , indicating that ELA-2 may represent an important player in cardiovascular diseases such as MI. ELA-2 produces Ang II by cleaving the Phe 8 -His 9 bond of Ang I, and it is not inhibited by captopril, but is sensitive to chymostatin (MacDonald et al., 1982; Santos et al., 2003 Santos et al., , 2004 Becari et al., 2005) . Chymostatin inhibits chymases (Urata et al., 1990; Takai et al., 2001 ) and ELA-2 (Santos et al., 2002a,b; , being considered a selective inhibitor for this enzyme family and also effective against the rat ELA-2 (Santos et al., 2002a,b; Santos et al., 2004) . Although the use of chymostatin cannot unequivocally indicate the relative contributions of different serine proteases to Ang II generation in mice mesenteric bed, it is well documented that rat and mice chymases are mainly angiotensinases (Wintroub et al., 1984; Le Trong et al., 1987; Chandrasekharan et al., 1996; Kunori et al., 2005) , which argues in favour of ELA-2 as the enzyme responsible for ACE-independent pathway in Ang II generation in the mesenteric artery (Paula et al., 1998; Santos et al., 2002a,b) . In fact, mouse chymases, MMCP-1 and MMCP-4, but not rat chymases, can form Ang II from Ang I (Caughey et al., 2000; Saito et al., 2003) . Kunori et al. (2005) analysed the processing of Ang I by chymases in a variety of species [human chymase, dog chymase, hamster chymase-1, rat mast cell protease-1 (rMCP-1), mouse mast cell protease-4 (mMCP-4)]. Human chymase generated Ang II from Ang I without further degradation of the productAng II, whereas chymases of other species generated Ang II, followed by its degradation at the ). These results suggest species differences in the contribution of chymases to local Ang II generation and degradation. When purified rat ELA-2 is incubated with Ang I, the products formed are Ang II and His-Leu; no other fragments are identified, even after prolonged incubations. In addition, as shown in Supporting Information Figure S1 , rat and mice mesenteric arterial bed perfusates contained Ang II, Ang-(1-7) and Ang-(1-9) formed from Ang I and Ang I conversion to Ang II was equally inhibited in the presence of SBTI. Overall, our results suggest that both rat and mouse MAB contain/exhibit the same proteolytic array, with ELA-2 contributing to Ang II generation. Therefore, the effects of protease inhibitors on the contractile responses to Ang II precursors were studied in an attempt to determine the relative importance of ACE and non-ACE pathways for Ang II generation. Chymostatin induced a rightward shift of the vasoconstrictor effect of Ang I in sham-WT mice mesenteric arteries, thus indicating that a non-ACE pathway, as seen for ELA-2, also converts Ang I into Ang II. On the other hand, chymostatin did not affect the responses to Ang I in sham-ELA-2 KO, reinforcing the suggestion that ELA-2 is the alternative pathway for Ang II generation in mouse mesenteric resistance arteries. Chymostatin did not affect the responses to Ang II either BJP C Becari et al.
in sham-animals or in mice subjected to MI. These data clearly indicate that ELA-2 contributes to Ang II generation in mouse resistance arteries and that ELA-2 is the major alternative or ACE-independent pathway for Ang IIgeneration in these arteries.
One limitation of the present study is that it lacks pharmacological analysis confirming the effects of ELA-2 inhibition. However, so far, there is no reliable method to distinguish human chymase versus murine ELA-2 activities. For example, the peptide Pro11-D-Ala12-Ang I, a biologically inactive precursor that selectively yields Ang II on incubation with chymases, but not with ACE or carboxypeptidases (Hoit et al., 1995) , has been extensively used as a selective chymase substrate. However, purified rat ELA-2 also efficiently produces Ang II from [Pro 11 -D-Ala 12 ]-Ang I (Santos et al., 2002a) , suggesting that in vivo or in vitro production of Ang II by chymases in rodents may have been overestimated in previous investigations. Additionally, human chymase and rat ELA-2 are equally sensitive to most general-purpose serine protease inhibitors as chymostatin, SBTI and PMSF. For example, the serine protease inhibitor chymostatin efficiently inhibits chymase and rat/mouse ELA-2. Data from our group show that chymostatin inhibits Ang II generation in mouse mesenteric arterial bed. The compound CH-5450 developed as a selective inhibitor for chymases (Bastos et al., 1995) also inhibited the rat mesenteric arterial bed ELA-2 activity towards the substrate Ang I (Santos et al., 2002a,b) . In addition, N-acetyl-Ala-Ala-Pro-Leu-chloromethyl ketone, an effective active site-directed inhibitor of human pancreatic ELA-2 (Largman et al., 1980) , efficiently blocks Ang II-generating activity of human chymase (Santos et al., 2002a,b) . We thought that the ELA-2 KO could overcome these deficiencies and would help us to understand the role of ELA-2 in vivo and Ang II generation independent of ACE or chymase. Ang I responses were left-shifted in mesenteric arteries of infarcted WT mice, indicating that Ang II generation from Ang I is increased after MI in peripheral resistance arteries. Patients with heart failure display augmented concentrations of Ang II, which is related to the pathological manifestations of heart failure (Serneri et al., 2001) . Mice overexpressing the angiotensinogen gene in the heart also exhibit increased ventricular Ang II formation and hypertrophy, suggesting that local Ang II generation contributes to cardiac remodelling (Mazzolai et al., 1998) . Our study provides evidence that MI also increases Ang II in peripheral resistance arteries and that ELA-2 is responsible for the local Ang II formation.
In physiological conditions, the constrictor response induced by Ang I was similar in sham-ELA-2 KO and sham-WT mice. Similarly, no differences were observed in the vascular response to Ang I between sham-ELA-2 and MI-ELA-2 KO arteries, suggesting that the alternative pathway to Ang I generation is important under pathological or pharmacological interventions. It is noteworthy that MI did not result in any significant changes in the vascular responses to Ang II, either in WT or ELA-2 KO groups. In mesenteric arteries from sham-WT and sham-ELA-2 KO mice, contractile responses elicited by Ang II and Ang I were highly reproducible and completely blocked by the AT 1 receptor antagonist losartan, indicating that the AT 1 receptor mediates vasoconstriction, as is the case in the rat carotid artery (Becari et al., 2005) .
Conclusion
Our data provide the first evidence that ELA-2 contributes to increased vascular Ang II formation and may contribute to cardiac dysfunction after MI, implicating this enzyme as a key player in ACE-independent dysregulation of the RAS.
